Implantable Cuff Electrode Arrangement for Selective Nerve Fiber Stimulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing therapeutic measures for arterial hypertension often result in significant side effects and fail to achieve adequate target blood pressure in up to 30% of patients, highlighting the need for alternative treatments that can selectively target and stimulate blood pressure-relevant nerve fibers.

Innovation Solution

An implantable electrode arrangement that includes a cuff electrode with a biocompatible carrier substrate and a dual electrode system, allowing for spatially-selective detection and stimulation of neuronal electrical signals in nerve fibers, while inhibiting unidirectional signal transfer along efferent nerve fibers to minimize side effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional blood pressure medication is administered, then blood pressure is reduced, but significant side effects occur and target blood pressure is not achieved in up to 30% of patients

Engineering Contradiction:
Improveblood pressure control effectivenessVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces pharmacological chemical action with electrical stimulation of the vagus nerve. Instead of using blood pressure-lowering drugs that cause side effects, the invention uses an implantable electrode arrangement to deliver electrical signals to specific nerve fibers, substituting a mechanical/electrical system for a chemical one.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The electrode arrangement features multiple electrode structures with different polarities (anodal and cathodal) arranged in specific patterns around the nerve fascicle. This creates localized electrical fields that selectively stimulate or inhibit specific nerve fibers while leaving others unaffected, enabling precise control without systemic side effects.

Inventive Principle:
Principle #3Local quality

2Object-affected harmful factors

If the electrode arrangement stimulates baroreceptive nerve fibers, then blood pressure is reduced with minimal side effects, but selective stimulation requires complex electrode structures

Engineering Contradiction:
Improveside effectsVSAvoidelectrode arrangement structure
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The electrode arrangement is divided into multiple discrete electrode structures (first, second, third electrode structures) with different functions. Each structure contains multiple electrode surfaces that can be independently controlled, allowing selective stimulation of specific nerve fiber groups while avoiding unwanted effects on others.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses a signal generator as an intermediary device that processes and delivers precisely controlled electrical signals to the electrode arrangement. This intermediary enables complex stimulation patterns to be achieved through software control rather than requiring equally complex hardware structures.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If the carrier substrate surface is made straight and cylinder-shaped, then spatially-selective detection and stimulation is enabled, but manufacturing precision requirements increase

Engineering Contradiction:
Improvespatial resolution of nerve fiber detectionVSAvoidcarrier substrate surface geometry
Core Design Contradiction:
Measurement precisionVSManufacturing precision

Solution Approach 1:

The carrier substrate is formed as a cylinder-shaped structure that can be placed around the nerve fascicle in a cuff configuration. This curved geometry naturally conforms to the cylindrical shape of nerves, providing consistent contact and precise spatial positioning without requiring high-precision flat surface manufacturing.

Inventive Principle:
Principle #14Spheroidality (Curvature)

Solution Approach 2:

The carrier substrate is made as a thin, flexible structure that can be bent into a cylindrical shape and wrapped around the nerve fascicle. This flexibility allows the substrate to adapt to the nerve's geometry while maintaining precise electrode positioning, reducing manufacturing precision requirements compared to rigid structures.

Inventive Principle:
Principle #30Flexible shells and thin films

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The electrode arrangement effectively reduces blood pressure with minimal side effects, such as bradycardia and bradypnoea, by selectively stimulating baroreceptive nerve fibers and inhibiting efferent nerve fiber stimulation, thus providing a more targeted and gentle treatment approach.

Implementation Method 1

spatially-selective detection of neuronal electrical signals, which propagate along at least one nerve fiber

Methodology Applied
Scientific EffectElectrical signal detection: Conduction (electrical)

Implementation Method 2

selective electrical stimulation of the at least one selected nerve fiber

Methodology Applied
Scientific EffectElectrical stimulation: Conduction (electrical)

Implementation Method 3

inhibiting unidirectional signal transfer along efferent nerve fibers

Methodology Applied
Scientific EffectElectrical inhibition: Conduction (electrical)

Data Source

PatentUS12343523B2Implantable electrode arrangement
Publication Date: 2025.07.01 NEUROLOOP
  • US12343523B2 patent drawing
  • US12343523B2 patent drawing
  • US12343523B2 patent drawing

AI summary

An implantable electrode arrangement provides spatially-selective detection of neuronal electrical signals, which propagate along at least one nerve fiber contained in a nerve fascicle, and for selective electrical stimulation of the at least one nerve fiber, comprising a biocompatible carrier substrate, which has at least one carrier substrate region that can be placed around the nerve fascicle in a cuff and has a straight cylinder-shaped carrier substrate surface which faces the nerve fascicle in the implanted state. The carrier substrate surface has an axial extension and an extension oriented circumferentially in a direction and a first electrode arrangement attached thereto. The electrode arrangement comprises in an axial sequence, at least three first electrode structures with at least two first electrode surfaces arranged in the circumferentially, and at least two spaced first electrode strips, displayed in the axial direction which extend circumferentially which are in a ring shape, which encloses the at least three electrode structures on both sides in the axial direction. The electrodes are connectable or are connected to a signal detector and generator.